Meeting
2023 ASCO Annual Meeting
The significance of mucin on rectal MRI in patients with locally advanced rectal cancer being considered for watch-and-wait after neoadjuvant therapy.
Authors
Sean Judge
Memorial Sloan Kettering Cancer Center, New York, NY
Sean Judge , Parisa Malekzadeh , Marina J Corines , Marc J Gollub , Natally Horvat , Leonard B. Saltz , Andrea Cercek , Paul Bernard Romesser , Christopher H Crane , Iris H Wei , Maria Widmar , Emmanouil Pappou , Garrett Michael Nash , Jesse Joshua Smith , Philip Paty , Julio Garcia-Aguilar , Martin R. Weiser
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3614)
DOI
10.1200/JCO.2023.41.16_suppl.3614
Abstract #
3614
Poster Bd #
314
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Outcomes of younger patients diagnosed with locally advanced rectal cancer.
First Author: Rosemary Habib
Poster
2018 Gastrointestinal Cancers Symposium
Influence of timing of surgery on perioperative morbidity after neoadjuvant therapy for locally advanced rectal cancer.
First Author: Campbell SD Roxburgh
Poster
2017 Gastrointestinal Cancers Symposium
Evolution in multimodality management of locally advanced rectal cancer.
First Author: Campbell SD Roxburgh
Poster
2013 Gastrointestinal Cancers Symposium
Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer.
First Author: Junichi Hasegawa